MSH2 and hepatocellular carcinoma: The result of the multiplicative interaction analysis was shown in Table 4, and the risk of HCC attributable to the interaction of MSH3-rs181747 (CC) and MSH2-rs4952887 (CC) was 1.773 (P=0.007, OR=1.773).